This paper is in the following e-collection/theme issue:

#xPublicandGlobalHealth (34) Infectious Diseases (non-STD/STI) (1592) Public Health (207) Infectious Diseases (non-STD/STI) (1592) Outbreak and Pandemic Preparedness and Management (1743) Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1520) #xInfectiousDiseases (28) Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1520) Outbreak and Pandemic Preparedness and Management (1743) Public Health (207) #xInfectiousDiseases (28)

Published on in Vol 4 (2023)

Preprints (earlier versions) of this paper are available at https://www.medrxiv.org/content/10.1101/2020.08.04.20168112v1, first published .
Seroprevalence of SARS-CoV-2 in Niger State: Pilot Cross-Sectional Study

Seroprevalence of SARS-CoV-2 in Niger State: Pilot Cross-Sectional Study

Seroprevalence of SARS-CoV-2 in Niger State: Pilot Cross-Sectional Study

Authors of this article:

Hussaini Majiya1, 2, 3 Author Orcid Image ;   Mohammed Aliyu-Paiko2, 3, 4 Author Orcid Image ;   Vincent Tochukwu Balogu1, 2 Author Orcid Image ;   Dickson Achimugu Musa2, 3, 4 Author Orcid Image ;   Ibrahim Maikudi Salihu2, 5 Author Orcid Image ;   Abdullahi Abubakar Kawu2, 3, 6 Author Orcid Image ;   Ishaku Yakubu Bashir2, 7 Author Orcid Image ;   Aishat Rabiu Sani1, 2, 3 Author Orcid Image ;   John Baba1, 2 Author Orcid Image ;   Amina Tako Muhammad2, 8 Author Orcid Image ;   Fatimah Ladidi Jibril1, 2 Author Orcid Image ;   Ezekiel Bala1, 2 Author Orcid Image ;   Nuhu George Obaje2 Author Orcid Image ;   Yahaya Badeggi Aliyu2, 8 Author Orcid Image ;   Ramatu Gogo Muhammad1, 2 Author Orcid Image ;   Hadiza Mohammed2, 4 Author Orcid Image ;   Usman Naji Gimba2, 5 Author Orcid Image ;   Abduljelili Uthman2, 4 Author Orcid Image ;   Hadiza Muhammad Liman2, 7 Author Orcid Image ;   Sule Alfa Alhaji9 Author Orcid Image ;   Joseph Kolo James10 Author Orcid Image ;   Muhammad Muhammad Makusidi10 Author Orcid Image ;   Mohammed Danasabe Isah9 Author Orcid Image ;   Ibrahim Abdullahi2, 6 Author Orcid Image ;   Umar Ndagi3, 9, 11 Author Orcid Image ;   Bala Waziri11 Author Orcid Image ;   Chindo Ibrahim Bisallah1 Author Orcid Image ;   Naomi John Dadi-Mamud2, 5 Author Orcid Image ;   Kolo Ibrahim1, 2 Author Orcid Image ;   Abu Kasim Adamu2, 5 Author Orcid Image
Article Authors Cited by (5) Tweetations (4) Metrics

Journals

  1. Majiya H, Aliyu-Paiko M, Balogu V, Musa D, Salihu I, Kawu A, Bashir I, Sani A, Baba J, Muhammad A, Jibril F, Bala E, Obaje N, Aliyu Y, Muhammad R, Mohammed H, Gimba U, Uthman A, Liman H, Alhaji S, James J, Makusidi M, Isah M, Abdullahi I, Ndagi U, Waziri B, Bisallah C, Dadi-Mamud N, Ibrahim K, Adamu A. Authors’ Response to Peer Reviews of “Seroprevalence of SARS-CoV-2 in Niger State: Pilot Cross-Sectional Study”. JMIRx Med 2023;4:e50515 View
  2. Ofori S, Schwind J, Sullivan K, Chowell G, Cowling B, Fung I. Modeling the health impact of increasing vaccine coverage and nonpharmaceutical interventions against coronavirus disease 2019 in Ghana. Pathogens and Global Health 2024;118(3):262 View
  3. Mutevedzi P, Lokotfwako V, Kwatra G, Maphalala G, Baillie V, Dlamini L, Dlamini S, Mhlanga F, Dlamini T, Nhlabatsi N, Nunes M, Zwane S, Madhi S. Prevalence and Levels of Anti-SARS-CoV-2 Antibodies in the Eswatini Population and Subsequent Severity of the Fourth COVID-19 Epidemic Wave. COVID 2024;4(3):317 View
  4. Ramalan M, Musa B, Abdullahi R, Abdullahi A, Damagum F. Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Nigeria: A Systematic Review and Meta Analysis of Seroprevalence Studies. Nigerian Journal of Medicine 2023;32(5):453 View
  5. Sana A, Djemaï E, De Vreyer P, Thivillon T, Badolo H, Berthé A, Kania D, Roques P. Seroprevalence and risk factors for SARS-CoV-2 infection in middle-sized cities of Burkina Faso: A descriptive cross-sectional study. PLOS ONE 2024;19(8):e0305850 View